GW-501516 (10MG) (50 TABLETS)

The Compound That Is Transforming Metabolic & Endurance Research

Few research compounds have generated as much scientific excitement and investigational momentum as GW-501516 (10MG) (50 TABLETS). Known across the global research community as Cardarine, GW-501516 is a highly selective PPARδ (Peroxisome Proliferator-Activated Receptor delta) agonist whose extraordinary capacity to modulate fatty acid metabolism, mitochondrial biogenesis, and skeletal muscle fiber composition has made it one of the most studied and most sought-after compounds in modern metabolic biology. At Peptides Lab, we supply this remarkable research tool in a precise 10mg per tablet formulation across a 50-tablet supply — giving US research teams the consistent, purity-verified compound substrate they need to explore one of the most consequential molecular targets in contemporary biomedical science.

The scientific community’s interest in PPARδ agonism has grown steadily over the past two decades, driven by the receptor’s central role in regulating energy expenditure, lipid homeostasis, and skeletal muscle adaptation. When GW-501516 binds to and activates PPARδ, it triggers a transcriptional program that shifts cellular metabolism toward enhanced fatty acid oxidation, suppresses glucose utilization in muscle tissue, and promotes the development of slow-twitch, oxidative muscle fibers with superior endurance characteristics. These downstream effects have profound implications for research into metabolic disease, obesity biology, cardiovascular health, and exercise physiology — making GW-501516 (10MG) (50 TABLETS) from Peptides Lab an essential compound for any US research institution working at the frontier of metabolic science.

Where GW-501516 (10MG) (50 TABLETS) Delivers Unmatched Research Value

The true scientific power of GW-501516 (10MG) (50 TABLETS) lies in its extraordinary versatility across research disciplines. For investigators who are actively studying ==what a gene is== at the functional level — examining how specific genetic sequences translate into measurable physiological outcomes — GW-501516 offers a uniquely precise investigational tool. PPARδ activation by GW-501516 triggers highly specific changes in gene expression across metabolic tissues, making it an ideal compound for transcriptomic studies seeking to map the relationship between nuclear receptor activation and downstream gene regulatory networks. US genomics research programs, particularly those at major academic medical centers in Boston, San Diego, and Research Triangle Park in North Carolina, have leveraged GW-501516 extensively in exactly this kind of gene expression mapping work.

Researchers working in the domain of growth hormone biology and peptide science have also found GW-501516 (10MG) (50 TABLETS) to be a compound of compelling interest. Scientists studying ==retratutide== — the next-generation triple receptor agonist that has drawn significant investigational attention for its effects on body composition and metabolic regulation — frequently incorporate GW-501516 into comparative study designs to examine how PPARδ-mediated metabolic reprogramming interacts with incretin-based signaling pathways. This intersection of receptor pharmacology represents one of the most productive and rapidly evolving research territories in current US biomedical science, and Peptides Lab is proud to supply both compounds at the purity levels these sophisticated investigations demand.

The relevance of GW-501516 (10MG) (50 TABLETS) extends further into the domain of developmental and endocrine research. Investigators studying ==pituitary dwarfism== — a condition arising from insufficient growth hormone production due to pituitary dysfunction — have identified PPARδ signaling as a potentially significant modulator of the somatotropic axis, with implications for understanding how metabolic status influences GH secretion and downstream IGF-1 activity. Research teams at US pediatric endocrinology programs and growth disorder research centers have incorporated GW-501516 into their investigational frameworks precisely because of this mechanistic overlap between metabolic biology and the growth hormone axis.

The compound’s applications in molecular biology research are equally significant. Scientists examining ==tetracycline repressor protein== systems — widely used in inducible gene expression research as a tool for controlling transgene activation — have incorporated GW-501516 into studies designed to understand how metabolic state and PPARδ activity influence inducible promoter systems in metabolically active tissues. This application sits at the intersection of molecular tool development and metabolic biology, and it reflects the extraordinary breadth of research contexts in which GW-501516 proves scientifically valuable. Additionally, researchers utilizing ==southern hybridisation== techniques to map PPARδ target gene loci and examine how GW-501516-mediated receptor activation reshapes the genomic landscape of metabolic tissues have found this compound indispensable to their investigational workflow. And for investigators applying ==nucleic acid amplification== methodologies to quantify changes in PPARδ target gene expression following GW-501516 treatment, our purity-verified formulation ensures that compound variability never becomes a confounding variable in their transcriptomic data sets.

Peptides Lab Quality: The Benchmark US Researchers Rely On

At Peptides Lab, every batch of GW-501516 (10MG) (50 TABLETS) is independently HPLC-tested to confirm purity at ≥99%, and your batch-specific Certificate of Analysis is included with every order — no exceptions, no excuses. We ship from US domestic warehousing to research institutions across all 50 states, ensuring that scientists in New York, Los Angeles, Chicago, Houston, Seattle, Miami, and everywhere in between receive their compounds with speed, reliability, and full compound integrity intact.

Order GW-501516 (10MG) (50 TABLETS) from Peptides Lab today — and give your PPARδ research the compound quality it demands.